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ABSTRACT 
Objective: Pre-eclampsia is associated with maternal cardiac remodelling and 
diastolic dysfunction. The aim of this study was to assess and compare 
maternal left ventricular structure and diastolic function and Brain Natriuretic 
Peptide (BNP) levels in women with early-onset pre-eclampsia (<34 weeks of 
gestation) and late-onset pre-eclampsia (≥ 34weeks of gestation).  
Methods: A prospective, cross-sectional observational study was performed in 
30 women with early-onset pre-eclampsia, 32 with late-onset pre-eclampsia and 
23 normotensive controls. Maternal cardiac structure and diastolic function as 
assessed by echocardiography and plasma levels of BNP were measured by 
enzyme immunoassay.  
Results: Pre-eclampsia was associated with an increased left ventricular mass 
index and relative wall thickness in early-onset pre-eclampsia compared with 
late-onset pre-eclampsia and normotensive controls. The prevalence of 
concentric hypertrophy (40%) and diastolic dysfunction (23%) was also 
significantly higher in early-onset pre-eclampsia than in late-onset pre-
eclampsia (16% for both, all p<0.05). Maternal serum BNP values were also 
significantly higher in early-onset pre-eclampsia (p<0.05) and correlated with 
relative wall thickness and left ventricular mass index.  
Conclusions: Early-onset pre-eclampsia has more severe cardiac impairment 
than late-onset pre-eclampsia as evidenced by increased prevalence of 
concentric hypertrophy, diastolic dysfunction and high concentrations BNP. 
These findings suggest that early-onset pre-eclampsia causes greater 
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myocardial damage increasing the risk of both peripartum and postpartum 
cardiovascular morbidity. Although these cardiovascular effects are easily 
identified by echocardiographic parameters and measuring BNP, further studies 
are needed to assess their clinical utility.  
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INTRODUCTION 
 Pre-eclampsia (PE) is associated with significant maternal morbidity and 
mortality and affects 5% - 7% of pregnant patients worldwide. It is 
predominantly a disorder with cardiovascular manifestations, which is clinically 
identified by hypertension and proteinuria occurring after the 20th week of 
gestation1.  
 Recent evidence indicates that there are two main time of onset of PE. 
Early-onset (before34 weeks’ gestation) and late-onset (at or after 34 weeks’ 
gestation),3,4 suggesting that different pathophysiological mechanisms may 
contribute to the timing of PE onset2. PE is commonly associated with abnormal 
placental pathology and placenta mediated complications such as fetal growth 
restriction. Previous studies have shown that women with PE have an increased 
risk of developing cardiovascular disease in the future - the risk being much 
higher in those with early-onset and severe PE5,6,7. Recent investigations have 
also demonstrated that PE is associated with altered levels of angiogenic 
factors and abnormalities of cardiac function, namely impaired myocardial 
relaxation and diastolic dysfunction – which is more severe in early-onset PE8.  
 Cardiac myocytes release B-type natriuretic peptide (BNP), and its 
inactive N-terminal fragment cleavage product N-terminal pro-BNP, into the 
blood in response to stress. Measurements of BNP have been shown to be 
sensitive markers for the detection of mild systolic or diastolic heart failure or 
asymptomatic left ventricular dysfunction9, and for the diagnosis of congestive 
heart failure in patients with dyspnoea in an acute-care setting. Although, a few 
recent studies have suggested that BNP levels are elevated in pregnancy and 
PE, it is not known whether this biochemical response is non-specific or directly 
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related to the degree of diastolic dysfunction seen in pregnancy and PE10,11. 
The aim of this study is to assess and compare maternal left ventricular 
structure and diastolic function and Brain Natriuretic Peptide (BNP) levels in 
women with early-onset pre-eclampsia and late-onset pre-eclampsia.  
 
METHODS 
 
This was a prospective cross-sectional study carried out over a 3-year 
period from January 2009, in antenatal clinic at department of Obstetrics and 
Gynaecology, Botucatu Medical School, Brazil. All women with singleton 
pregnancy and PE were recruited after informed consent and with local 
institutional review committee approval. Only women without comorbidities, and 
before starting any medication, were asked to take part in the study. Pre-
eclampsia was defined according to the International Society for the Study of 
Hypertension in Pregnancy guidelines12. The PE group was divided into two 
subgroups: early onset PE, which included those who developed PE at less 
than 34 gestational weeks and late onset PE, in those who developed PE at 34 
gestational weeks at least13. Subjects were categorised as having severe PE 
according to the guidelines of the International Society for Study of 
Hypertension in Pregnancy (ISSHP)12. The control group was recruited and 
matched for gestational age with the preeclamptic groups at time of sampling. 
These women remained normotensive until the end of gestation. Body mass 
index (BMI), systolic blood pressure (SBP) and diastolic blood pressure (DBP) 
were measured and a physical examination was performed. Maternal blood 
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pressure was measured manually from the brachial artery using a mercury 
sphygmomanometer according to the guidelines of the ISSHP12. 
 
BNP measurement 
 Blood sampling (10mL) was standardised without a tourniquet and all 
samples were centrifuged immediately twice, at 2000 rpm to separate plasma. 
Blood samples were collected at the time of the echocardiography 
examinations. Specimens were stored (- 80oC) until analysis. BNP was 
measured using an ELISA method (Wuhan EIAab, Science Co., Ltd, China, cat 
no. E0541h). The limit of detection for the BNP method was 3.90pg/mL and 
the intra- and inter-assay precision was less than 10% and 15% respectively. 
 
Echocardiography 
  
Ultrasound examinations were performed with a Vivid S6 da GE (General 
Electric), by one expert investigator (S.G.Z.). The two-dimensional, M-mode and 
Doppler echocardiography were acquired according to the guidelines of the 
American Society of Echocardiography and stored digitally14. Standard 
echocardiographic measurements included LV end-diastolic dimensions 
(LVDd), end-diastolic wall thickness of the interventricular septum (IVSd) and 
left ventricular posterior wall (PWTd). The left ventricular mass (LVM) was 
calculated according to the Devereux and Reichek formula. The LV mass index 
(LVMi) was calculated by the indexation of LV mass by height2.7.The relative 
wall thickness (RWT) was calculated according to the formula (RWT) = [(IVSd + 
PWTd)/2] / LVDd, where IVSd is the interventricular septum dimension, PWT is 
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the posterior wall thickness and LVDd is the left ventricular diastolic diameter. 
Left ventricular hypertrophy was defined as LVMi ≥ 45g/m2,7, considered 
concentric hypertophy when RWT>0.42 and eccentric hypertrophy when 
RWT<0.4215.Transmitral, pulmonary venous flow velocities were acquired with 
pulsed Doppler. The velocities of early transmitral diastolic flow velocity (E) and 
flow velocity during atrial contraction (A), its ratio (E/A), and deceleration time 
(DT) and isovolumic relaxation time (IVRT) were measured. Diastolic 
dysfunction was defined as ratio (E/A <1.0 and/or IVRT>100ms and 
DT>180cm/s). Doppler-derived indices were averaged from between three and 
five consecutive cardiac cycles. 
 
Statistical methods 
 
 Data were analysed using INSTAT software (GraphPad, San Diego, 
USA, 2000). All variables were compared using Kruskal-Wallis test, followed by 
Dunn's multiple comparison test, except birth weight variable, which ANOVA 
test was used. The Spearman rank order correlation coefficient was used to 
measure the association between some of the variables. P<.05 was considered 
statistically significant. A sample size of 28 in each subgroup PE was calculated 
to observe a 75% difference in standard deviation of the BNP between cases 
and control subjects. A significance level of 5% (α= 0.05) and statistical power 
of 80% (β= 0.20) were considered.  
RESULTS 
The study group consisted of 30 women with early-onset PE, 32 with 
late-onset PE and 23 normotensive controls. The demographic and clinical 
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characteristics of the study participants are shown in Table 1. There were no 
differences in the maternal age and body mass index between the groups. 
Women with early onset PE had significantly higher systolic and diastolic blood 
pressure than those with late onset PE (P= .05). 
 Results of echocardiographic geometric patterns and diastolic function 
are presented in Table 2. Women with early onset PE had increased relative 
wall thickness and prevalence of concentric hypertrophy (0.43 and 40%, 
respectively) compared to those with late onset PE (0.38 and 16%, respectively; 
both p<.05). No significant difference in eccentric hypertrophy in both of groups 
(late onset PE= 31% vs early onset pre-eclampsia = 10%, p= 0.085). Seven 
women with early-onset PE (23%) and five with late-onset PE (16%) 
demonstrated diastolic dysfunction compared with none in the control group,  
(p<0.05). Other parameters of diastolic function were not different between 
groups.  
 There was a significant graded increase in median BNP levels between 
controls (43pg/mL), late onset PE (147pg/mL) and early onset PE (214pg/mL; 
P<.05; Figure 1). There were significant correlations between BNP and relative 
wall thickness and left ventricular mass index in women with PE (Table 3, 
Figures 2 and 3). 
 
 
DISCUSSION 
  
The present study demonstrates that women with early-onset PE exhibit 
more severe cardiovascular impairment compared to those with late onset PE – 
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and that the magnitude of cardiovascular dysfunction was correlated with a 
significant increase in plasma concentrations of BNP. Both groups of PE 
present a significant increases in left atrial diameter, relative wall thickness, left 
ventricular mass index, flow velocity during atrial contraction (A), lower E/A ratio 
and altered left ventricular geometry in comparison with normal pregnancy. 
 In normal pregnancy, left ventricular mass index increases without 
changes in the ratio of wall thickness to cavity dimensions, indicative of a 
preload-mediated heart remodelling15,16. In PE, is a state of arterial 
vasoconstriction leading to an increased afterload, with high total vascular 
resistance17. The maternal heart responds to the acute and transient increase in 
afterload, with a process of adaptation characterised by remodelling, and 
sometimes concentric hypertrophy, despite the brevity of exposure of the heart 
to hypertension18,19. Previous studies have demonstrated that the increased 
LVM is accompanied by an increase in cardiac work suggesting that heart 
remodelling in PE is a response to the increased systemic afterload in order to 
minimise myocardial oxygen demand and thus preserving left ventricular 
performance20. 
 Valensise et al.4 compared maternal cardiac function at 24 weeks 
gestation in a group of normotensive asymptomatic patients with the 
subsequent development of early and late-onset PE. In this study, pregnant 
women with early-onset PE showed increased relative wall thickness and 
smaller LV diameter compared to the control groups and late-onset PE. These 
results demonstrate concentric hypertrophy, suggesting significant pressure 
overload in early-onset PE. Conversely, late-onset PE showed greater LV 
diameter, with an intermediate value of the left relative thickness wall compared 
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with early-onset PE and the control group, featuring eccentric hypertrophy, 
characteristic of volume overload 20,21,22. A recent study found progression 
towards severe left ventricular hypertrophy in association with advanced cardiac 
dysfunction in about 20% of preterm preeclamptic women. This indicates that 
although most women with PE undergo adaptive heart remodelling to increased 
afterload, a small subgroup demonstrate signs of overt decompensation23.  
 Our echocardiographic findings are consistent with those of Valensise et 
al.4 and Melchiorre et al.23. PE women had a higher incidence of concentric 
hypertrophy, especially in the early onset PE (40%). The relevance of this result 
is the evidence that concentric LVH is a risk marker for diastolic dysfunction, the 
abnormal accumulation of interstitial collagen in the myocardium and reduced 
coronary reserve. Our study did not include analyses to assess coronary flow 
reserve, or composition of the myocardium, but the echocardiographic exams 
showed that early-onset PE associated concentric hypertrophy had diastolic 
dysfunction, suggesting potential damage in the myocardium. The mechanisms 
of dysfunction may not completely understand the results obtained. However, it 
is possible to suggest that the ventricles of small cavities and thick walls are 
less compliant. Thus, normal or even reduced blood volumes could result in 
increased filling pressure, characterising diastolic dysfunction. 
 Cardiac dysfunction can be associated with increased concentrations of 
natriuretic peptides, since these neurohormones are produced by the heart in 
cases of cardiac overload24. Currently, the clinical use of natriuretic peptides for 
diagnosis and risk stratification in heart failure is well established25; however, 
there are conflicting results with regard to BNP levels during pregnancy26,27. In 
our study, early-onset PE showed significantly higher BNP levels than late-
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onset PE group and normotensive women. In late-onset PE, BNP values were 
higher than in the control group. Furthermore, 97% of pregnant women with 
early-onset PE and 84.3% of women with late-onset PE showed mean 
concentrations of BNP above100 pg/mL, which is considered a threshold for the 
diagnosis of dyspnoea of cardiac etiologic in non-pregnant women. Natriuretic 
peptides are recognised in non-pregnant individuals as markers of myocardial 
hypertrophy associated with cardiac dysfunction. Our study found a strong 
positive correlation between the concentration of BNP, LVMi and relative wall 
thickness in women with PE. 
 
Study limitations 
 Apart from the small numbers and cross-sectional of our study, it should 
be noted that values of BNP are variable in previous pregnancy studies. For 
example, in our study, the average value of BNP in normal pregnancy 
(43pg/mL) was higher than that reported in other studies (20 pg/dL).These 
results can be explained by the recognized differences in both population and 
assay techniques. 
 
Conclusions 
 The increased BNP levels in PE confirm that the observed maternal echo 
indices represent overt maternal diastolic dysfunction rather than an extended 
physiological adaptation in pregnancy. Furthermore, early-onset PE is 
characterised by an increased prevalence of concentric hypertrophy and LV 
diastolic dysfunction and higher BNP levels compared to late-onset PE 
suggesting that this entity causes greater myocardial damage increasing the 
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risk of per partum and postpartum cardiovascular sequelae. Although these 
cardiovascular effects are easily identified by echocardiographic parameters 
and a high plasma concentration of BNP, further studies are needed to assess 
the clinical utility of such measures. 
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TABLE 1 – Clinical characteristics in the control, late-onset PE and early-onset 
PE groups. 
 
Controls 
(n =23) 
Late-onset PE 
(n=32) 
Early-onset PE 
(n=30) 
Maternal age (y) 27(22-33) 24(19-30) 25 (20-32) 
BMI at assessment 
(Kg/m2) 
27.4 (26.0-29.7) 30.8 (27.4-36.0) 31.6 (26.5-33.9) 
Gestational age at 
assessment (week) 
34 (29-37) 37 (36-38)† 32 (23-33)*,† 
Gestational age at 
delivery (week) 
40 (39-40) 37 (37-38)† 32 (28-33)*,† 
Birth weight (g)   3410 (426) 2976 (471) 1351 (557)*,† 
Systolic pressure at 
diagnosis (mmHg) 
110 (103-112) 150 (140-160)† 160 (150-170)*,† 
Diastolic pressure at 
diagnosis (mmHg) 
69(63-70) 100 (90-100)† 110 (102-120)*,† 
BMI: body mass index. Data are expressed as median (interquartile) or as mean (± 
SD). *p< .05 versus late-onset PE; †p< .05 versus controls by Kruskal-Wallis, followed 
by Dunn's multiple comparison test or by Anova (birth weight). 
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TABLE 2 – Echocardiographic geometric patterns and diastolic function in the 
control, late-onset PE and early-onset PE groups.  
 Controls 
(n =23) 
Late-onset PE 
(n=32) 
Early-onset PE 
 (n=30) 
Cardiac geometry 
Left atrial diameter (mm) 37(36-37) 41(39-42)† 40 (37-42)† 
LVDD (mm) 47(45-47) 46(45-48)* 46(45-48)* 
LVSD (mm) 28(27-29) 29 (27-31) 27(24-28)* 
Relative wall thickness 0.35(0.35-0.36) 0.38(0.36-0.44)† 0.43(0.40-0.47)*,† 
LVM (g) 122(115-127) 158(152-170)† 152(132-185)† 
LVMi (g/m2.7) 35(32-38) 44(42-49)† 44 (36-52)† 
LV eccentric hypertrophy 0 10 (31%)† 3 (10%)† 
LV concentric hypertrophy 0 5 (16%)† 12 (40%)*, † 
Diastolic function 
E/A ratio 1.7(1.5-1.9) 1.5(1.3-1.7)† 1.4(1.3-1.6)† 
IVRT (ms) 81(81-89) 87(80-95) 88(81-96) 
Deceleration time (ms) 194(185-200) 192 (187-206) 201(188-219) 
Diastolic dysfunction# 0 5 (16%) 7 (23%)† 
LVDD: left ventricular diastolic diameter; LVSD: left ventricular systolic diameter;   LVM: 
left ventricular mass; LVMi: left ventricular mass index; E wave: early transmitral 
diastolic flow velocity; A wave: flow velocity during atrial contraction; IVRT: isovolumic 
relaxation time.  
Data are expressed as median (interquartile) or as number (percentage). *p< .05 
versus late-onset PE; †p< .05 versus controls by Kruskal-Wallis, followed by Dunn's 
multiple comparison test. 
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TABLE 3 – Spearman´s correlations between BNP and E/A, LAD, LVDD, PWT, 
RWT and LVMi in late-onset PE and early-onset PE groups.  
 
 
Late-onset PE vs 
BNP (pg/mL) 
Early-onset PE vs 
BNP (pg/mL) 
 r p r p 
E/A ratio - 0.3319 .0731 -0.2814 .1551 
LAD (mm) 0.2094 .2666 0.5546 .0027 
LVDD (mm) -0.1331 0.4832 0.1725 0.3896 
PWT (mm) 0.5003 0.0049 0.7011 <0.001 
RWT 0.4787 .0074 0.5688 .0020 
LVMi (g/m2.7) 0.6596 <.0001 0.7132 <.0001 
BNP: Brain Natriuretic Peptide; E wave: early transmitral diastolic flow velocity; A wave: 
flow velocity during atrial contraction; LAD: left atrial diameter; LVDD: left ventricular 
diastolic diameter; PWT: posterior wall thickness; RWT: relative wall thickness; LVMi: 
left ventricular mass index; r=Spearman’s. 
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FIGURE LEGENDS 
 
Figure 1: BNP level (pg/mL) in control, late-onset pre-eclampsia (LOPE) and 
early-onset pre-eclampsia (EOPE) groups. 
 
Figure 2: Correlation between BNP level (pg/mL) and relative wall thickness 
(RWT) in control, late-onset pre-eclampsia (LOPE) and early-onset pre-
eclampsia (EOPE) groups. 
 
Figure 3: Correlation between BNP level (pg/mL) and left ventricular mass 
index (LVMi) in control, late-onset pre-eclampsia (LOPE) and early-onset pre-
eclampsia (EOPE) groups. 
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*p< .05 versus late-onset PE; †p< .05 versus controls 
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